From January 29 to February 1, FUSE-AI will be present in Za'abeel Hall, booth Z6, F46 and is looking forward to introducing the functionality of Prostate.Carcinoma.ai, our AI-based software to facilitate MRI analysis for radiologists.

In December, our software was certified according to (EU) MDR for medical devices class IIa. Now, manufacturers of PACS and diagnostic DICOM viewers have the opportunity to integrate Prostate.Carcinoma.ai, an AI-based solution, seamlessly into their systems. We provide proven time savings in segmentation and calculation of the prostate, its zones and suspicious lesions for MRI analysis.

Investors are also invited to find out more about FUSE-AI's business model and take advantage of the opportunity to join in an up-coming and dynamic start-up.

Those who are being absent are welcome to schedule a demo via its booking system